Last reviewed · How we verify
NCT03948880
Incidence OIRD Medical and Trauma Patients
trial in Respiratory Depression in 101 participants. Status unknown.
29 October 2019
Quick facts
| Lead sponsor | Community Health System |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 101 |
| Start date | 29 July 2019 |
| Primary completion | 29 October 2019 |
| Estimated completion | 29 November 2019 |
| Sites | 1 location across United States |
Conditions studied
- Respiratory Depression — all drugs for Respiratory Depression →
- Sedation — all drugs for Sedation →
Sponsor
Community Health System
Who can join
Adults 18 to 89, any sex, with Respiratory Depression or Sedation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this prospective, blinded observational study is to correlate assessment of sedation and respiratory status with capnography and pulse oximetry monitoring in hospitalized adult medical and trauma patients receiving patient-controlled analgesia (PCA) or nurse administered intravenous opioids for acute pain. Nursing assessment of respiratory status and sedation level will be correlated with capnography and pulse oximetry values as technology-supported monitoring to identify respiratory depression and opioid-induced sedation. The secondary objective is to identify capnography and pulse oximetry values that correlate with respiratory decompensation and opioid-induced sedation in medical and trauma patients on the general care floor.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03948880
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Depression
Currently open trials in the same condition.
- NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
- NCT06967259 — ENA-001 for Opioid Induced Respiratory Depression · Phase 1 · active not recruiting
- NCT06823661 — Transcutaneous Electrical Stimulation for Apnea Detected by Capnography · NA · recruiting
- NCT06777758 — Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments · Phase 4 · recruiting
- NCT06772961 — Effect of Percutaneous Electrical Acupoint Stimulation on the Improvement of Incidence of Adverse Respiratory Events · NA · recruiting
Other Community Health System trials
Trials by the same sponsor.
- NCT03554811 — Early Rehabilitation Using Functional Electrical Stimulation Assisted Supine Cycling in the Intensive Care Unit · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03948880 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Community Health System
- Last refreshed: 31 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03948880.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing